Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E Ratio 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.09x
EV / EBIT 14.8x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.62
EBIT 1 4.122
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 8/26/25 A
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 912K
-128.03x10.49x-145.14x-.--% 30.37B
18.49x1.79x10.36x1.09% 21.83B
16.51x1.29x7.29x5.33% 7.04B
290.82x - - - 4.46B
52.79x9.32x32.7x0.87% 2.82B
31.04x1.25x10.31x0.81% 1.79B
-19.99x - - - 1.78B
34.63x1.52x12.38x1.55% 1.73B
11.94x1.26x4.94x6.34% 1.63B
Average 34.24x 3.85x -9.59x 2.29% 7.34B
Weighted average by Cap. -24.84x 5.95x -59.39x 1.17%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!